Web Stats Provided By Google Analytics

Monday, April 21, 2014

Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to...

Can-Fite's A3AR predictive biomarker kit is designed for use at any molecular biology lab prior to treatment to help identify an individual patient's responsiveness to the Company's drugs, thus providing personalized medicine.

http://ift.tt/PmFGap

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts